ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

UCAR vs NIKI // 10Y YIELD & FRED MACRO BETA

U Power Limited (Class A) (NASDAQ) VS. Niki BioSolutions Inc. (NASDAQ) • 15-METRIC TALLY: UCAR 2 — NIKI 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UCAR VS. NIKI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC UCAR NIKI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 36.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -18.50% -5.90% -12.60 NIKI /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -3.60% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 UCAR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.4 27.1 +3.30 UCAR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.1M $5.7M -$689.4K NIKI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR UCAR REV NIKI REV UCAR GROSS % NIKI GROSS % UCAR FCF NIKI FCF
FY 2025 $5.9M $0 36.3% — -$10.0M -$1.8M
FY 2024 $6.1M $0 23.6% — -$10.0M -$1.2M
FY 2023 $2.8M $431.4K — — -$9.2M -$7.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UCAR // BETA —
NIKI // BETA —